Analgesic effect of the continuous bilateral transversus abdominis plane block using levobupivacaine after gynecological laparotomy; continuous block versus single-injection block.A double-blind trial.

Analgesic effect of the continuous bilateral transversus abdominis plane block using levobupivacaine after gynecological laparotomy; continuous block versus single-injection block.A double-blind trial. - Analgesic effect of the continuous bilateral transversus abdominis plane block using levobupivacaine after gynecological laparotomy; continuous block versus single-injection block.A double-blind trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008949

Enrollment

Registered

2012-10-01

Start date

2012-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who are scheduled for laparotomy in gynecologic cancer and may have pelvic lymph node biopsy or dissection.

Interventions

Patients will receive ultrasound-guided transversus abdominis plane block.They will receive analgesia through a catheter placed into transversus abdominis plane and connected to levobupivacaine infusi

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.Patients who are scheduled for laparotomy in gynecologic cancer and may have pelvic lymph node biopsy or dissection in Osaka University Hospital 2.Patients who receive subcutaneous heparin for prophylaxis of deep venous thrombosis and cannot receive epidural anesthesia 3. Patients who can give written informed consent

Exclusion criteria

Exclusion criteria: 1.Patinets who have risk factor in American Society of Anesthesiologists physical status over 3 2.Patinets who are allergic to local anesthetics 3.Pantients who have abdominal pain before surgery or use analgetic drugs for chronic pain 4.Patients who have severe paralysis or severe neurologic disease 5.Patients who are regarded ineligible by doctors with any other reasons

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale (VAS) pain scores at rest and at mobilization after 6,15 and 24hours postoperation.	—

Secondary

Measure	Time frame
1.Incidence of nausea and vomitting 2.Incidence of drousiness 3.Postoperative fentanyl consumption 4.Additional analgesics 5.Ocurrence of local anesthetic intoxication 6.Effect site concentration of fentanyl at the discharge from operating room and at the visit	—

Countries

Japan

Contacts

Public ContactSho Carl Shibata

Graduate School of Medicine, Osaka University Department of Anesthesiology and Intensive Care Medicine

06-6879-3313

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026